Impedance threshold device as a countermeasure for spaceflight associated neuro-ocular syndrome (SANS): Mitigating mechanisms in proposed pathophysiology.


Journal

Life sciences in space research
ISSN: 2214-5532
Titre abrégé: Life Sci Space Res (Amst)
Pays: Netherlands
ID NLM: 101632373

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 14 02 2024
revised: 31 05 2024
accepted: 05 06 2024
medline: 28 7 2024
pubmed: 28 7 2024
entrez: 27 7 2024
Statut: ppublish

Résumé

Long-duration spaceflight (LDSF) is associated with unique hazards and linked with numerous human health risks including Spaceflight Associated Neuro-ocular Syndrome (SANS). The proposed mechanisms for SANS include microgravity induced cephalad fluid shift and increased Intracranial Pressure (ICP). SANS is a disorder seen only after LDSF and has no direct terrestrial pathologic counterpart as the zero G environment cannot be completely replicated on Earth. Head-down tilt, bed rest studies however have been used as a terrestrial analog and produce the cephalad fluid shift. Some proposed countermeasures for SANS include vasoconstrictive thigh cuffs and lower body negative pressure. Another potential researched countermeasure is the impedance threshold device (ITD) which can reduce ICP. We review the mechanisms of the ITD and its potential use as a countermeasure for SANS.

Identifiants

pubmed: 39067998
pii: S2214-5524(24)00064-6
doi: 10.1016/j.lssr.2024.06.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-107

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare no competing interests.

Auteurs

Mohammed Tayyib Masood (MT)

Newcastle University Medical School, Framlington, United Kingdom.

Jen-Wei Willy Wang (JW)

Newcastle University Medical School, Framlington, United Kingdom.

Eleni Angeliki Zoumi (EA)

University of Exeter Medical School, Exeter, United Kingdom.

Kinshuk Jain (K)

Leeds School of Medicine, Leeds, United Kingdom.

Alex Suh (A)

Tulane University School of Medicine, New Orleans, LA, United States.

Joshua Ong (J)

Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States.

Ethan Waisberg (E)

Department of Ophthalmology, University of Cambridge, Cambridge, United Kingdom.

Mouayad Masalkhi (M)

University College Dublin School of Medicine, Belfield, Dublin, Ireland.

Andrew G Lee (AG)

Center for Space Medicine, Baylor College of Medicine, Houston, Texas, United States; Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, United States; The Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas, United States; Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, New York, New York, United States; Department of Ophthalmology, University of Texas Medical Branch, Galveston, Texas, United States; University of Texas MD Anderson Cancer Center, Houston, Texas, United States; Texas A&M College of Medicine, Bryan, Texas, United States; Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States. Electronic address: aglee@houstonmethodist.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH